Back to Jacobs Levy Equity Management, Inc. Jacobs Levy Equity Management, Inc.

RNAC

5 quarters

Position history for Jacobs Levy Equity Management, Inc.Jacobs Levy Equity Management, Inc.'s holdings in Cartesian Therapeutics, Inc.

No. Jacobs Levy Equity Management exited its RNAC (Cartesian Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 101,534 shares worth $624,434. Jacobs Levy Equity Management first reported RNAC in Q2 2025 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$429,284

Total Shares Change

-41,317

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$10.42
0
2026-Q1
Increased
101,534
+6.0%
$624,4340.0%$7.48
26
2025-Q4
Increased
95,799
+219.3%
$690,7110.0%$6.94
40
2025-Q3
Decreased
30,001
-27.4%
$306,6100.0%$10.22
0
2025-Q2
New
41,317
-
$429,2840.0%$10.39
33

Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC

Optional analytics helps us improve. How it’s used